Medical Editor: John P. Cunha, DO, FACOEP
- injection site reactions (infection, swelling, blood clot, or fluid leakage), or
- increase in blood volume (hypervolemia)
Dosage of Plasma-Lyte 148 depends on the age, weight and condition of the patient. Plasma-Lyte 148 may interact with corticosteroids or corticotropin. Tell your doctor all medications and supplements you take. Plasma-Lyte 148 should be used during pregnancy only if clearly needed. Consult your doctor before breastfeeding.
Our Plasma-Lyte 148 and 5% Dextrose Injection (multiple electrolytes and dextrose) Side Effects Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
Read the entire FDA prescribing information for Plasma-Lyte 148 (Multiple Electrolytes Inj)
© Plasma-Lyte 148 Patient Information is supplied by Cerner Multum, Inc. and Plasma-Lyte 148 Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.
Health Solutions From Our Sponsors